跳至主要内容
临床试验/CTRI/2022/04/041923
CTRI/2022/04/041923已完成2 期

Double-blind, randomized, placebo-controlled efficacy trial of individualized homoeopathic medicines in toothache

D N De Homoeopathic Medical College Hospital0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from enlargement of alveolar ridge NOS, insufficient anatomic crown height, insufficient clinical crown length, irregular alveolar process, toothache NOS (ICD-10 code K08.89)
  • 2. Patients suffering from toothache due to injury, dental caries, dental abscess, periodontitis, eruption of teeth, etc.
  • 3. Age between 18 and 65 years
  • 4. Patients of either sex
  • 5. Habit of brushing teeth with toothbrush and fluoridated toothpaste at least once daily
  • 6. Literate patients; ability to read English and/or Bengali and/or Hindi
  • 7. Providing with written informed consent

排除标准

  • 1. Other orofacial pain conditions of non-odontogenic origin
  • 2. Recent steroid or antibiotic therapy for dental pain, gingivitis, periodontitis, etc.
  • 3. Spontaneous bleeding gum associated with systemic disorder
  • 4. Patients who are too sick for consultation
  • 5. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
  • 6. Pregnant and puerperal women, lactating mothers
  • 7. Vulnerable population – unconscious, ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, institutionalized subjects, mentally incompetent people
  • 8. Habit of tobacco chewing, smoking and different other form(s) of substance abuse and/or dependence
  • 9. Self-reported immune-compromised state
  • 10.Already undergoing homoeopathic treatment for chronic disease within last 2 weeks

研究者

相似试验

已完成
2 期
Homeopathic treatment of breast lumps
CTRI/2022/04/041949D N De Homoeopathic Medical College Hospital63
进行中(未招募)
1 期
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering Therapy
EUCTR2005-003511-75-SKDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering TherapyPediatric Heterozygous Familial Hypercholesterolemia (heFH)MedDRA version: 8.1Level: LLTClassification code 10057079Term: Heterozygous familial hypercholesterolemia
EUCTR2005-003511-75-CZDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering Therapy
EUCTR2005-003511-75-HUDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering Therapy - WEL-410
EUCTR2005-003511-75-ATSankyo Pharma Development (SPhD)200
Homeopathic medicines for pain in tooth | 临床试验